Posted by Michael Wonder on 19 Feb 2020
Trio of prescription cost bills pass off Senate floor
19 February 2020 - The Washington Senate on Tuesday passed three bills that aim to reign in the costs of prescription drugs.
Two of the measures, all sponsored by Democratic Sen. Karen Keiser, address insulin costs, while the third addresses overall drug affordability.
A measure that would cap the monthly out-of-pocket cost of insulin to $100 until 1 January 2023 and requires the Health Care Authority to monitor the price of insulin, passed on a 34-14 vote.
